Reuters
GlaxoSmithKline and Pfizer, two of the world’s leading developers of AIDS drugs, are pooling their resources by creating a specialist HIV company focused on the disease. FULL STORY
Glaxo and Pfizer pool AIDS drugs in new company
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content